nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PTGS2—head and neck cancer	0.537	1	CbGaD
Meloxicam—ABCC4—Fluorouracil—head and neck cancer	0.186	0.594	CbGbCtD
Meloxicam—CYP2C8—Fluorouracil—head and neck cancer	0.0533	0.17	CbGbCtD
Meloxicam—CYP2C9—Fluorouracil—head and neck cancer	0.0372	0.119	CbGbCtD
Meloxicam—CYP3A4—Vinblastine—head and neck cancer	0.02	0.064	CbGbCtD
Meloxicam—CYP3A4—Docetaxel—head and neck cancer	0.0165	0.0527	CbGbCtD
Meloxicam—Lornoxicam—PTGS2—head and neck cancer	0.00215	0.41	CrCbGaD
Meloxicam—Tenoxicam—PTGS2—head and neck cancer	0.00192	0.365	CrCbGaD
Meloxicam—ABCC4—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00138	0.0525	CbGpPWpGaD
Meloxicam—Piroxicam—PTGS2—head and neck cancer	0.00118	0.226	CrCbGaD
Meloxicam—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—head and neck cancer	0.00108	0.0412	CbGpPWpGaD
Meloxicam—ABCC4—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.000918	0.0349	CbGpPWpGaD
Meloxicam—Pancytopenia—Vinblastine—head and neck cancer	0.000811	0.00686	CcSEcCtD
Meloxicam—Pancreatitis—Hydroxyurea—head and neck cancer	0.000764	0.00646	CcSEcCtD
Meloxicam—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000751	0.00635	CcSEcCtD
Meloxicam—Myocardial infarction—Vinblastine—head and neck cancer	0.000747	0.00631	CcSEcCtD
Meloxicam—Pancytopenia—Hydroxyurea—head and neck cancer	0.00074	0.00626	CcSEcCtD
Meloxicam—Photosensitivity—Fluorouracil—head and neck cancer	0.000739	0.00625	CcSEcCtD
Meloxicam—Swelling—Fluorouracil—head and neck cancer	0.000736	0.00622	CcSEcCtD
Meloxicam—Disorientation—Fluorouracil—head and neck cancer	0.000725	0.00613	CcSEcCtD
Meloxicam—Agranulocytosis—Vinblastine—head and neck cancer	0.000711	0.00601	CcSEcCtD
Meloxicam—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.000709	0.006	CcSEcCtD
Meloxicam—Weight increased—Hydroxyurea—head and neck cancer	0.000709	0.006	CcSEcCtD
Meloxicam—Drug interaction—Docetaxel—head and neck cancer	0.000695	0.00588	CcSEcCtD
Meloxicam—Infestation NOS—Hydroxyurea—head and neck cancer	0.000695	0.00587	CcSEcCtD
Meloxicam—Infestation—Hydroxyurea—head and neck cancer	0.000695	0.00587	CcSEcCtD
Meloxicam—Drowsiness—Hydroxyurea—head and neck cancer	0.000695	0.00587	CcSEcCtD
Meloxicam—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000693	0.0264	CbGpPWpGaD
Meloxicam—Haemoglobin—Vinblastine—head and neck cancer	0.000687	0.00581	CcSEcCtD
Meloxicam—Haemorrhage—Vinblastine—head and neck cancer	0.000684	0.00578	CcSEcCtD
Meloxicam—PGD—NRF2 pathway—TGFA—head and neck cancer	0.000681	0.0259	CbGpPWpGaD
Meloxicam—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000679	0.00574	CcSEcCtD
Meloxicam—Pharyngitis—Vinblastine—head and neck cancer	0.000679	0.00574	CcSEcCtD
Meloxicam—Stomatitis—Hydroxyurea—head and neck cancer	0.000677	0.00573	CcSEcCtD
Meloxicam—Cardiac failure—Fluorouracil—head and neck cancer	0.000665	0.00562	CcSEcCtD
Meloxicam—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000657	0.00556	CcSEcCtD
Meloxicam—ABCC4—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000654	0.0248	CbGpPWpGaD
Meloxicam—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000649	0.00549	CcSEcCtD
Meloxicam—Blood pressure increased—Docetaxel—head and neck cancer	0.000645	0.00546	CcSEcCtD
Meloxicam—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000631	0.024	CbGpPWpGaD
Meloxicam—Haemoglobin—Hydroxyurea—head and neck cancer	0.000627	0.0053	CcSEcCtD
Meloxicam—Influenza like illness—Docetaxel—head and neck cancer	0.000627	0.0053	CcSEcCtD
Meloxicam—Haemorrhage—Hydroxyurea—head and neck cancer	0.000624	0.00527	CcSEcCtD
Meloxicam—Colitis—Docetaxel—head and neck cancer	0.000619	0.00524	CcSEcCtD
Meloxicam—Alopecia—Vinblastine—head and neck cancer	0.000604	0.00511	CcSEcCtD
Meloxicam—Oesophagitis—Docetaxel—head and neck cancer	0.00059	0.00499	CcSEcCtD
Meloxicam—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00058	0.00491	CcSEcCtD
Meloxicam—Lightheadedness—Docetaxel—head and neck cancer	0.000577	0.00488	CcSEcCtD
Meloxicam—Angiopathy—Hydroxyurea—head and neck cancer	0.000566	0.00478	CcSEcCtD
Meloxicam—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000564	0.0215	CbGpPWpGaD
Meloxicam—Ill-defined disorder—Vinblastine—head and neck cancer	0.000552	0.00467	CcSEcCtD
Meloxicam—Alopecia—Hydroxyurea—head and neck cancer	0.000551	0.00466	CcSEcCtD
Meloxicam—Anaemia—Vinblastine—head and neck cancer	0.00055	0.00465	CcSEcCtD
Meloxicam—Angina pectoris—Fluorouracil—head and neck cancer	0.000546	0.00462	CcSEcCtD
Meloxicam—Erythema—Hydroxyurea—head and neck cancer	0.000543	0.00459	CcSEcCtD
Meloxicam—Malaise—Vinblastine—head and neck cancer	0.000537	0.00454	CcSEcCtD
Meloxicam—Vertigo—Vinblastine—head and neck cancer	0.000535	0.00452	CcSEcCtD
Meloxicam—Leukopenia—Vinblastine—head and neck cancer	0.000533	0.00451	CcSEcCtD
Meloxicam—Pancytopenia—Fluorouracil—head and neck cancer	0.000533	0.0045	CcSEcCtD
Meloxicam—Swelling—Docetaxel—head and neck cancer	0.000531	0.00449	CcSEcCtD
Meloxicam—ABCC4—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000523	0.0199	CbGpPWpGaD
Meloxicam—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000521	0.00441	CcSEcCtD
Meloxicam—Hepatic failure—Docetaxel—head and neck cancer	0.000521	0.00441	CcSEcCtD
Meloxicam—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000516	0.00437	CcSEcCtD
Meloxicam—Convulsion—Vinblastine—head and neck cancer	0.000516	0.00436	CcSEcCtD
Meloxicam—Hypertension—Vinblastine—head and neck cancer	0.000514	0.00435	CcSEcCtD
Meloxicam—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000514	0.0195	CbGpPWpGaD
Meloxicam—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000512	0.00433	CcSEcCtD
Meloxicam—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000504	0.00426	CcSEcCtD
Meloxicam—Anaemia—Hydroxyurea—head and neck cancer	0.000502	0.00424	CcSEcCtD
Meloxicam—Discomfort—Vinblastine—head and neck cancer	0.000501	0.00423	CcSEcCtD
Meloxicam—Hot flush—Docetaxel—head and neck cancer	0.000501	0.00423	CcSEcCtD
Meloxicam—Infestation—Fluorouracil—head and neck cancer	0.0005	0.00423	CcSEcCtD
Meloxicam—Infestation NOS—Fluorouracil—head and neck cancer	0.0005	0.00423	CcSEcCtD
Meloxicam—Menopausal symptoms—Docetaxel—head and neck cancer	0.000496	0.0042	CcSEcCtD
Meloxicam—Visual disturbance—Docetaxel—head and neck cancer	0.000494	0.00418	CcSEcCtD
Meloxicam—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000493	0.00417	CcSEcCtD
Meloxicam—Renal impairment—Docetaxel—head and neck cancer	0.000492	0.00416	CcSEcCtD
Meloxicam—Myocardial infarction—Fluorouracil—head and neck cancer	0.00049	0.00414	CcSEcCtD
Meloxicam—Dermatitis bullous—Docetaxel—head and neck cancer	0.00049	0.00414	CcSEcCtD
Meloxicam—Malaise—Hydroxyurea—head and neck cancer	0.00049	0.00414	CcSEcCtD
Meloxicam—Stomatitis—Fluorouracil—head and neck cancer	0.000487	0.00412	CcSEcCtD
Meloxicam—Urinary tract infection—Fluorouracil—head and neck cancer	0.000486	0.00411	CcSEcCtD
Meloxicam—Conjunctivitis—Fluorouracil—head and neck cancer	0.000486	0.00411	CcSEcCtD
Meloxicam—Leukopenia—Hydroxyurea—head and neck cancer	0.000486	0.00411	CcSEcCtD
Meloxicam—Cardiac failure—Docetaxel—head and neck cancer	0.00048	0.00406	CcSEcCtD
Meloxicam—Thrombocytopenia—Vinblastine—head and neck cancer	0.000476	0.00402	CcSEcCtD
Meloxicam—Convulsion—Hydroxyurea—head and neck cancer	0.00047	0.00398	CcSEcCtD
Meloxicam—Sinusitis—Fluorouracil—head and neck cancer	0.000469	0.00397	CcSEcCtD
Meloxicam—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000468	0.00396	CcSEcCtD
Meloxicam—Pain in extremity—Docetaxel—head and neck cancer	0.000468	0.00396	CcSEcCtD
Meloxicam—Agranulocytosis—Fluorouracil—head and neck cancer	0.000467	0.00395	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000459	0.00388	CcSEcCtD
Meloxicam—Discomfort—Hydroxyurea—head and neck cancer	0.000457	0.00386	CcSEcCtD
Meloxicam—Haemoglobin—Fluorouracil—head and neck cancer	0.000451	0.00382	CcSEcCtD
Meloxicam—Rhinitis—Fluorouracil—head and neck cancer	0.00045	0.00381	CcSEcCtD
Meloxicam—Haemorrhage—Fluorouracil—head and neck cancer	0.000449	0.0038	CcSEcCtD
Meloxicam—Pharyngitis—Fluorouracil—head and neck cancer	0.000446	0.00377	CcSEcCtD
Meloxicam—Oedema—Hydroxyurea—head and neck cancer	0.000443	0.00375	CcSEcCtD
Meloxicam—Infection—Hydroxyurea—head and neck cancer	0.00044	0.00372	CcSEcCtD
Meloxicam—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000437	0.0166	CbGpPWpGaD
Meloxicam—Paraesthesia—Vinblastine—head and neck cancer	0.000436	0.00369	CcSEcCtD
Meloxicam—Dehydration—Docetaxel—head and neck cancer	0.000436	0.00368	CcSEcCtD
Meloxicam—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000435	0.00367	CcSEcCtD
Meloxicam—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000434	0.00367	CcSEcCtD
Meloxicam—Liver function test abnormal—Docetaxel—head and neck cancer	0.000432	0.00366	CcSEcCtD
Meloxicam—Skin disorder—Hydroxyurea—head and neck cancer	0.00043	0.00364	CcSEcCtD
Meloxicam—Abdominal pain upper—Docetaxel—head and neck cancer	0.000428	0.00362	CcSEcCtD
Meloxicam—Decreased appetite—Vinblastine—head and neck cancer	0.000422	0.00357	CcSEcCtD
Meloxicam—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000422	0.00357	CcSEcCtD
Meloxicam—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000422	0.00357	CcSEcCtD
Meloxicam—Nasopharyngitis—Docetaxel—head and neck cancer	0.000419	0.00354	CcSEcCtD
Meloxicam—Constipation—Vinblastine—head and neck cancer	0.000415	0.00351	CcSEcCtD
Meloxicam—Pain—Vinblastine—head and neck cancer	0.000415	0.00351	CcSEcCtD
Meloxicam—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000413	0.00349	CcSEcCtD
Meloxicam—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—head and neck cancer	0.000408	0.0155	CbGpPWpGaD
Meloxicam—Arrhythmia—Fluorouracil—head and neck cancer	0.000401	0.00339	CcSEcCtD
Meloxicam—Feeling abnormal—Vinblastine—head and neck cancer	0.0004	0.00339	CcSEcCtD
Meloxicam—Bronchospasm—Docetaxel—head and neck cancer	0.000398	0.00337	CcSEcCtD
Meloxicam—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000397	0.00336	CcSEcCtD
Meloxicam—Alopecia—Fluorouracil—head and neck cancer	0.000397	0.00335	CcSEcCtD
Meloxicam—PGD—NRF2 pathway—GSTM1—head and neck cancer	0.000395	0.015	CbGpPWpGaD
Meloxicam—Dyspnoea—Hydroxyurea—head and neck cancer	0.000395	0.00334	CcSEcCtD
Meloxicam—Angina pectoris—Docetaxel—head and neck cancer	0.000394	0.00333	CcSEcCtD
Meloxicam—Somnolence—Hydroxyurea—head and neck cancer	0.000394	0.00333	CcSEcCtD
Meloxicam—Erythema—Fluorouracil—head and neck cancer	0.000391	0.0033	CcSEcCtD
Meloxicam—Dyspepsia—Hydroxyurea—head and neck cancer	0.00039	0.0033	CcSEcCtD
Meloxicam—Decreased appetite—Hydroxyurea—head and neck cancer	0.000385	0.00326	CcSEcCtD
Meloxicam—Pancytopenia—Docetaxel—head and neck cancer	0.000384	0.00325	CcSEcCtD
Meloxicam—Abdominal pain—Vinblastine—head and neck cancer	0.000384	0.00325	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000383	0.00323	CcSEcCtD
Meloxicam—Fatigue—Hydroxyurea—head and neck cancer	0.000382	0.00323	CcSEcCtD
Meloxicam—Pain—Hydroxyurea—head and neck cancer	0.000379	0.0032	CcSEcCtD
Meloxicam—Constipation—Hydroxyurea—head and neck cancer	0.000379	0.0032	CcSEcCtD
Meloxicam—Weight increased—Docetaxel—head and neck cancer	0.000368	0.00312	CcSEcCtD
Meloxicam—Vision blurred—Fluorouracil—head and neck cancer	0.000368	0.00311	CcSEcCtD
Meloxicam—Weight decreased—Docetaxel—head and neck cancer	0.000366	0.0031	CcSEcCtD
Meloxicam—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000365	0.00309	CcSEcCtD
Meloxicam—Anaemia—Fluorouracil—head and neck cancer	0.000361	0.00305	CcSEcCtD
Meloxicam—Infestation—Docetaxel—head and neck cancer	0.000361	0.00305	CcSEcCtD
Meloxicam—Infestation NOS—Docetaxel—head and neck cancer	0.000361	0.00305	CcSEcCtD
Meloxicam—Hypersensitivity—Vinblastine—head and neck cancer	0.000358	0.00303	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000358	0.00303	CcSEcCtD
Meloxicam—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000356	0.00301	CcSEcCtD
Meloxicam—Renal failure—Docetaxel—head and neck cancer	0.000355	0.003	CcSEcCtD
Meloxicam—Myocardial infarction—Docetaxel—head and neck cancer	0.000354	0.00299	CcSEcCtD
Meloxicam—Jaundice—Docetaxel—head and neck cancer	0.000352	0.00297	CcSEcCtD
Meloxicam—Stomatitis—Docetaxel—head and neck cancer	0.000352	0.00297	CcSEcCtD
Meloxicam—Conjunctivitis—Docetaxel—head and neck cancer	0.000351	0.00297	CcSEcCtD
Meloxicam—Body temperature increased—Hydroxyurea—head and neck cancer	0.00035	0.00296	CcSEcCtD
Meloxicam—Leukopenia—Fluorouracil—head and neck cancer	0.00035	0.00296	CcSEcCtD
Meloxicam—Asthenia—Vinblastine—head and neck cancer	0.000349	0.00295	CcSEcCtD
Meloxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000346	0.0132	CbGpPWpGaD
Meloxicam—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000341	0.00289	CcSEcCtD
Meloxicam—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000339	0.0129	CbGpPWpGaD
Meloxicam—Convulsion—Fluorouracil—head and neck cancer	0.000339	0.00286	CcSEcCtD
Meloxicam—Agranulocytosis—Docetaxel—head and neck cancer	0.000337	0.00285	CcSEcCtD
Meloxicam—PTGS1—Overview of nanoparticle effects—BCL2—head and neck cancer	0.000336	0.0128	CbGpPWpGaD
Meloxicam—CYP2C8—Xenobiotics—CYP1A1—head and neck cancer	0.000333	0.0127	CbGpPWpGaD
Meloxicam—Myalgia—Fluorouracil—head and neck cancer	0.000333	0.00281	CcSEcCtD
Meloxicam—Diarrhoea—Vinblastine—head and neck cancer	0.000332	0.00281	CcSEcCtD
Meloxicam—Discomfort—Fluorouracil—head and neck cancer	0.000329	0.00278	CcSEcCtD
Meloxicam—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000326	0.00276	CcSEcCtD
Meloxicam—PTGS2—C-MYB transcription factor network—CEBPA—head and neck cancer	0.000326	0.0124	CbGpPWpGaD
Meloxicam—Haemoglobin—Docetaxel—head and neck cancer	0.000326	0.00275	CcSEcCtD
Meloxicam—Rhinitis—Docetaxel—head and neck cancer	0.000325	0.00275	CcSEcCtD
Meloxicam—Haemorrhage—Docetaxel—head and neck cancer	0.000324	0.00274	CcSEcCtD
Meloxicam—Hepatitis—Docetaxel—head and neck cancer	0.000324	0.00274	CcSEcCtD
Meloxicam—Confusional state—Fluorouracil—head and neck cancer	0.000322	0.00272	CcSEcCtD
Meloxicam—Pharyngitis—Docetaxel—head and neck cancer	0.000322	0.00272	CcSEcCtD
Meloxicam—Dizziness—Vinblastine—head and neck cancer	0.000321	0.00272	CcSEcCtD
Meloxicam—CYP2C8—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00032	0.0122	CbGpPWpGaD
Meloxicam—Urinary tract disorder—Docetaxel—head and neck cancer	0.00032	0.00271	CcSEcCtD
Meloxicam—PTGS1—Overview of nanoparticle effects—PTGS2—head and neck cancer	0.00032	0.0121	CbGpPWpGaD
Meloxicam—Oedema peripheral—Docetaxel—head and neck cancer	0.000319	0.0027	CcSEcCtD
Meloxicam—Oedema—Fluorouracil—head and neck cancer	0.000319	0.0027	CcSEcCtD
Meloxicam—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000319	0.0027	CcSEcCtD
Meloxicam—Connective tissue disorder—Docetaxel—head and neck cancer	0.000318	0.00269	CcSEcCtD
Meloxicam—Asthenia—Hydroxyurea—head and neck cancer	0.000318	0.00269	CcSEcCtD
Meloxicam—Urethral disorder—Docetaxel—head and neck cancer	0.000318	0.00269	CcSEcCtD
Meloxicam—Infection—Fluorouracil—head and neck cancer	0.000317	0.00268	CcSEcCtD
Meloxicam—Nervous system disorder—Fluorouracil—head and neck cancer	0.000313	0.00264	CcSEcCtD
Meloxicam—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000312	0.00264	CcSEcCtD
Meloxicam—Visual impairment—Docetaxel—head and neck cancer	0.000312	0.00264	CcSEcCtD
Meloxicam—Tachycardia—Fluorouracil—head and neck cancer	0.000311	0.00263	CcSEcCtD
Meloxicam—Vomiting—Vinblastine—head and neck cancer	0.000309	0.00261	CcSEcCtD
Meloxicam—Erythema multiforme—Docetaxel—head and neck cancer	0.000306	0.00259	CcSEcCtD
Meloxicam—Headache—Vinblastine—head and neck cancer	0.000304	0.00257	CcSEcCtD
Meloxicam—Diarrhoea—Hydroxyurea—head and neck cancer	0.000303	0.00256	CcSEcCtD
Meloxicam—Eye disorder—Docetaxel—head and neck cancer	0.000303	0.00256	CcSEcCtD
Meloxicam—Cardiac disorder—Docetaxel—head and neck cancer	0.000301	0.00254	CcSEcCtD
Meloxicam—Flushing—Docetaxel—head and neck cancer	0.000301	0.00254	CcSEcCtD
Meloxicam—Hypotension—Fluorouracil—head and neck cancer	0.000298	0.00252	CcSEcCtD
Meloxicam—Angiopathy—Docetaxel—head and neck cancer	0.000294	0.00249	CcSEcCtD
Meloxicam—Dizziness—Hydroxyurea—head and neck cancer	0.000293	0.00248	CcSEcCtD
Meloxicam—Immune system disorder—Docetaxel—head and neck cancer	0.000293	0.00247	CcSEcCtD
Meloxicam—Mediastinal disorder—Docetaxel—head and neck cancer	0.000292	0.00247	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000291	0.00246	CcSEcCtD
Meloxicam—Arrhythmia—Docetaxel—head and neck cancer	0.000289	0.00245	CcSEcCtD
Meloxicam—PGD—Metabolism—UROD—head and neck cancer	0.000289	0.011	CbGpPWpGaD
Meloxicam—Nausea—Vinblastine—head and neck cancer	0.000289	0.00244	CcSEcCtD
Meloxicam—Insomnia—Fluorouracil—head and neck cancer	0.000288	0.00244	CcSEcCtD
Meloxicam—PTGS2—C-MYB transcription factor network—CCNA1—head and neck cancer	0.000287	0.0109	CbGpPWpGaD
Meloxicam—Paraesthesia—Fluorouracil—head and neck cancer	0.000286	0.00242	CcSEcCtD
Meloxicam—Alopecia—Docetaxel—head and neck cancer	0.000286	0.00242	CcSEcCtD
Meloxicam—Dyspnoea—Fluorouracil—head and neck cancer	0.000284	0.0024	CcSEcCtD
Meloxicam—Mental disorder—Docetaxel—head and neck cancer	0.000284	0.0024	CcSEcCtD
Meloxicam—Somnolence—Fluorouracil—head and neck cancer	0.000284	0.0024	CcSEcCtD
Meloxicam—Malnutrition—Docetaxel—head and neck cancer	0.000282	0.00238	CcSEcCtD
Meloxicam—Erythema—Docetaxel—head and neck cancer	0.000282	0.00238	CcSEcCtD
Meloxicam—Vomiting—Hydroxyurea—head and neck cancer	0.000282	0.00238	CcSEcCtD
Meloxicam—Dyspepsia—Fluorouracil—head and neck cancer	0.000281	0.00237	CcSEcCtD
Meloxicam—Rash—Hydroxyurea—head and neck cancer	0.000279	0.00236	CcSEcCtD
Meloxicam—Dermatitis—Hydroxyurea—head and neck cancer	0.000279	0.00236	CcSEcCtD
Meloxicam—Headache—Hydroxyurea—head and neck cancer	0.000278	0.00235	CcSEcCtD
Meloxicam—Decreased appetite—Fluorouracil—head and neck cancer	0.000277	0.00234	CcSEcCtD
Meloxicam—Dysgeusia—Docetaxel—head and neck cancer	0.000276	0.00234	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000275	0.00233	CcSEcCtD
Meloxicam—Back pain—Docetaxel—head and neck cancer	0.000273	0.00231	CcSEcCtD
Meloxicam—Pain—Fluorouracil—head and neck cancer	0.000273	0.00231	CcSEcCtD
Meloxicam—Muscle spasms—Docetaxel—head and neck cancer	0.000271	0.00229	CcSEcCtD
Meloxicam—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000271	0.0103	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—TGFA—head and neck cancer	0.000271	0.0103	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—BCL2—head and neck cancer	0.000267	0.0102	CbGpPWpGaD
Meloxicam—PTGS1—Eicosanoid Synthesis—PTGS2—head and neck cancer	0.000265	0.0101	CbGpPWpGaD
Meloxicam—Nausea—Hydroxyurea—head and neck cancer	0.000263	0.00223	CcSEcCtD
Meloxicam—Feeling abnormal—Fluorouracil—head and neck cancer	0.000263	0.00222	CcSEcCtD
Meloxicam—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000261	0.00991	CbGpPWpGaD
Meloxicam—Anaemia—Docetaxel—head and neck cancer	0.000261	0.0022	CcSEcCtD
Meloxicam—Urticaria—Fluorouracil—head and neck cancer	0.000253	0.00214	CcSEcCtD
Meloxicam—Syncope—Docetaxel—head and neck cancer	0.000253	0.00214	CcSEcCtD
Meloxicam—Leukopenia—Docetaxel—head and neck cancer	0.000252	0.00213	CcSEcCtD
Meloxicam—Body temperature increased—Fluorouracil—head and neck cancer	0.000252	0.00213	CcSEcCtD
Meloxicam—PTGS1—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00025	0.00952	CbGpPWpGaD
Meloxicam—Palpitations—Docetaxel—head and neck cancer	0.000249	0.00211	CcSEcCtD
Meloxicam—Loss of consciousness—Docetaxel—head and neck cancer	0.000248	0.0021	CcSEcCtD
Meloxicam—PTGS1—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000248	0.00942	CbGpPWpGaD
Meloxicam—Cough—Docetaxel—head and neck cancer	0.000246	0.00208	CcSEcCtD
Meloxicam—Convulsion—Docetaxel—head and neck cancer	0.000244	0.00207	CcSEcCtD
Meloxicam—Hypertension—Docetaxel—head and neck cancer	0.000244	0.00206	CcSEcCtD
Meloxicam—Myalgia—Docetaxel—head and neck cancer	0.00024	0.00203	CcSEcCtD
Meloxicam—Arthralgia—Docetaxel—head and neck cancer	0.00024	0.00203	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000238	0.00202	CcSEcCtD
Meloxicam—Hypersensitivity—Fluorouracil—head and neck cancer	0.000235	0.00199	CcSEcCtD
Meloxicam—Dry mouth—Docetaxel—head and neck cancer	0.000235	0.00199	CcSEcCtD
Meloxicam—Confusional state—Docetaxel—head and neck cancer	0.000232	0.00196	CcSEcCtD
Meloxicam—Oedema—Docetaxel—head and neck cancer	0.00023	0.00195	CcSEcCtD
Meloxicam—Anaphylactic shock—Docetaxel—head and neck cancer	0.00023	0.00195	CcSEcCtD
Meloxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—head and neck cancer	0.000229	0.00872	CbGpPWpGaD
Meloxicam—Infection—Docetaxel—head and neck cancer	0.000229	0.00193	CcSEcCtD
Meloxicam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000228	0.00869	CbGpPWpGaD
Meloxicam—Shock—Docetaxel—head and neck cancer	0.000226	0.00192	CcSEcCtD
Meloxicam—Nervous system disorder—Docetaxel—head and neck cancer	0.000226	0.00191	CcSEcCtD
Meloxicam—Pruritus—Fluorouracil—head and neck cancer	0.000226	0.00191	CcSEcCtD
Meloxicam—Thrombocytopenia—Docetaxel—head and neck cancer	0.000225	0.00191	CcSEcCtD
Meloxicam—Tachycardia—Docetaxel—head and neck cancer	0.000225	0.0019	CcSEcCtD
Meloxicam—Skin disorder—Docetaxel—head and neck cancer	0.000224	0.00189	CcSEcCtD
Meloxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—head and neck cancer	0.000222	0.00843	CbGpPWpGaD
Meloxicam—Diarrhoea—Fluorouracil—head and neck cancer	0.000218	0.00185	CcSEcCtD
Meloxicam—Hypotension—Docetaxel—head and neck cancer	0.000215	0.00182	CcSEcCtD
Meloxicam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000214	0.00813	CbGpPWpGaD
Meloxicam—Dizziness—Fluorouracil—head and neck cancer	0.000211	0.00178	CcSEcCtD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.00021	0.00799	CbGpPWpGaD
Meloxicam—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00021	0.00177	CcSEcCtD
Meloxicam—Insomnia—Docetaxel—head and neck cancer	0.000208	0.00176	CcSEcCtD
Meloxicam—Paraesthesia—Docetaxel—head and neck cancer	0.000207	0.00175	CcSEcCtD
Meloxicam—Dyspnoea—Docetaxel—head and neck cancer	0.000205	0.00174	CcSEcCtD
Meloxicam—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000205	0.0078	CbGpPWpGaD
Meloxicam—Somnolence—Docetaxel—head and neck cancer	0.000205	0.00173	CcSEcCtD
Meloxicam—Vomiting—Fluorouracil—head and neck cancer	0.000203	0.00171	CcSEcCtD
Meloxicam—Dyspepsia—Docetaxel—head and neck cancer	0.000203	0.00171	CcSEcCtD
Meloxicam—Rash—Fluorouracil—head and neck cancer	0.000201	0.0017	CcSEcCtD
Meloxicam—Dermatitis—Fluorouracil—head and neck cancer	0.000201	0.0017	CcSEcCtD
Meloxicam—Decreased appetite—Docetaxel—head and neck cancer	0.0002	0.00169	CcSEcCtD
Meloxicam—PTGS2—S1P1 pathway—VEGFA—head and neck cancer	0.0002	0.0076	CbGpPWpGaD
Meloxicam—Headache—Fluorouracil—head and neck cancer	0.0002	0.00169	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000199	0.00168	CcSEcCtD
Meloxicam—PTGS2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000199	0.00755	CbGpPWpGaD
Meloxicam—Fatigue—Docetaxel—head and neck cancer	0.000198	0.00168	CcSEcCtD
Meloxicam—PTGS1—Biological oxidations—NAT2—head and neck cancer	0.000197	0.00749	CbGpPWpGaD
Meloxicam—Pain—Docetaxel—head and neck cancer	0.000197	0.00166	CcSEcCtD
Meloxicam—Constipation—Docetaxel—head and neck cancer	0.000197	0.00166	CcSEcCtD
Meloxicam—PTGS2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000197	0.00748	CbGpPWpGaD
Meloxicam—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000195	0.0074	CbGpPWpGaD
Meloxicam—Feeling abnormal—Docetaxel—head and neck cancer	0.00019	0.0016	CcSEcCtD
Meloxicam—Nausea—Fluorouracil—head and neck cancer	0.000189	0.0016	CcSEcCtD
Meloxicam—PTGS2—S1P1 pathway—MAPK3—head and neck cancer	0.000189	0.00719	CbGpPWpGaD
Meloxicam—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000188	0.00159	CcSEcCtD
Meloxicam—Abdominal pain—Docetaxel—head and neck cancer	0.000182	0.00154	CcSEcCtD
Meloxicam—Body temperature increased—Docetaxel—head and neck cancer	0.000182	0.00154	CcSEcCtD
Meloxicam—PTGS2—S1P1 pathway—MAPK1—head and neck cancer	0.00018	0.00684	CbGpPWpGaD
Meloxicam—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000179	0.0068	CbGpPWpGaD
Meloxicam—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000174	0.0066	CbGpPWpGaD
Meloxicam—ABCC4—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000174	0.0066	CbGpPWpGaD
Meloxicam—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000172	0.00654	CbGpPWpGaD
Meloxicam—Hypersensitivity—Docetaxel—head and neck cancer	0.00017	0.00143	CcSEcCtD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—head and neck cancer	0.000168	0.00637	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000167	0.00635	CbGpPWpGaD
Meloxicam—Asthenia—Docetaxel—head and neck cancer	0.000165	0.0014	CcSEcCtD
Meloxicam—Pruritus—Docetaxel—head and neck cancer	0.000163	0.00138	CcSEcCtD
Meloxicam—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000162	0.00615	CbGpPWpGaD
Meloxicam—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00016	0.00608	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000159	0.00605	CbGpPWpGaD
Meloxicam—Diarrhoea—Docetaxel—head and neck cancer	0.000157	0.00133	CcSEcCtD
Meloxicam—ABCC4—NRF2 pathway—GSTM1—head and neck cancer	0.000157	0.00598	CbGpPWpGaD
Meloxicam—Dizziness—Docetaxel—head and neck cancer	0.000152	0.00129	CcSEcCtD
Meloxicam—PTGS1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000147	0.0056	CbGpPWpGaD
Meloxicam—Vomiting—Docetaxel—head and neck cancer	0.000146	0.00124	CcSEcCtD
Meloxicam—Rash—Docetaxel—head and neck cancer	0.000145	0.00123	CcSEcCtD
Meloxicam—Dermatitis—Docetaxel—head and neck cancer	0.000145	0.00123	CcSEcCtD
Meloxicam—Headache—Docetaxel—head and neck cancer	0.000144	0.00122	CcSEcCtD
Meloxicam—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000138	0.00526	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—GSTM1—head and neck cancer	0.000137	0.00521	CbGpPWpGaD
Meloxicam—Nausea—Docetaxel—head and neck cancer	0.000137	0.00116	CcSEcCtD
Meloxicam—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000137	0.00519	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000133	0.00504	CbGpPWpGaD
Meloxicam—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000132	0.005	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000131	0.005	CbGpPWpGaD
Meloxicam—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00013	0.00495	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000129	0.00491	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000127	0.00484	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000126	0.00481	CbGpPWpGaD
Meloxicam—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000125	0.00477	CbGpPWpGaD
Meloxicam—PGD—Metabolism—NAT2—head and neck cancer	0.00012	0.00457	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00012	0.00455	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—VEGFA—head and neck cancer	0.000113	0.0043	CbGpPWpGaD
Meloxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000113	0.00428	CbGpPWpGaD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000112	0.00426	CbGpPWpGaD
Meloxicam—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000111	0.00422	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—head and neck cancer	0.000108	0.00412	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.000108	0.0041	CbGpPWpGaD
Meloxicam—PGD—Metabolism—DPYD—head and neck cancer	0.000105	0.004	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000104	0.00394	CbGpPWpGaD
Meloxicam—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000102	0.00388	CbGpPWpGaD
Meloxicam—PGD—Metabolism—YAP1—head and neck cancer	9.99e-05	0.0038	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	9.85e-05	0.00374	CbGpPWpGaD
Meloxicam—PTGS1—Biological oxidations—GSTM1—head and neck cancer	9.73e-05	0.0037	CbGpPWpGaD
Meloxicam—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	9.52e-05	0.00362	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	9.37e-05	0.00356	CbGpPWpGaD
Meloxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	9.26e-05	0.00352	CbGpPWpGaD
Meloxicam—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	9.22e-05	0.00351	CbGpPWpGaD
Meloxicam—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	9.18e-05	0.00349	CbGpPWpGaD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.13e-05	0.00347	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	8.87e-05	0.00337	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	8.86e-05	0.00337	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—BCL2—head and neck cancer	8.13e-05	0.00309	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—UROD—head and neck cancer	8.11e-05	0.00308	CbGpPWpGaD
Meloxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	7.75e-05	0.00294	CbGpPWpGaD
Meloxicam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	7.42e-05	0.00282	CbGpPWpGaD
Meloxicam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	7.33e-05	0.00279	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	7.18e-05	0.00273	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	7.12e-05	0.00271	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—CCND1—head and neck cancer	6.98e-05	0.00265	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—NAT2—head and neck cancer	6.83e-05	0.0026	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	6.73e-05	0.00256	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—UROD—head and neck cancer	6.44e-05	0.00245	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.29e-05	0.00239	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	6.28e-05	0.00239	CbGpPWpGaD
Meloxicam—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	6.2e-05	0.00236	CbGpPWpGaD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	6.02e-05	0.00229	CbGpPWpGaD
Meloxicam—PGD—Metabolism—TYMS—head and neck cancer	6e-05	0.00228	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	5.96e-05	0.00226	CbGpPWpGaD
Meloxicam—PGD—Metabolism—GSTM1—head and neck cancer	5.93e-05	0.00225	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—IL2—head and neck cancer	5.9e-05	0.00224	CbGpPWpGaD
Meloxicam—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	5.87e-05	0.00223	CbGpPWpGaD
Meloxicam—PGD—Metabolism—GPX1—head and neck cancer	5.68e-05	0.00216	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CYP1A1—head and neck cancer	5.62e-05	0.00214	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL2—head and neck cancer	5.45e-05	0.00207	CbGpPWpGaD
Meloxicam—PGD—Disease—NOTCH1—head and neck cancer	5.38e-05	0.00204	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CCND1—head and neck cancer	5.32e-05	0.00202	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—UROD—head and neck cancer	5.24e-05	0.00199	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	5.11e-05	0.00194	CbGpPWpGaD
Meloxicam—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	5.04e-05	0.00192	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	5.02e-05	0.00191	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5e-05	0.0019	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	4.91e-05	0.00187	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	4.85e-05	0.00184	CbGpPWpGaD
Meloxicam—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	4.78e-05	0.00182	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	4.75e-05	0.0018	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	4.52e-05	0.00172	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—HRAS—head and neck cancer	4.4e-05	0.00167	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MAPK3—head and neck cancer	4.39e-05	0.00167	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—UROD—head and neck cancer	4.26e-05	0.00162	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	4.21e-05	0.0016	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MAPK1—head and neck cancer	4.17e-05	0.00159	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—EGFR—head and neck cancer	4.17e-05	0.00159	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.06e-05	0.00155	CbGpPWpGaD
Meloxicam—PGD—Disease—PTGS2—head and neck cancer	3.99e-05	0.00152	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	3.92e-05	0.00149	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	3.62e-05	0.00138	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.58e-05	0.00136	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.54e-05	0.00135	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TP53—head and neck cancer	3.5e-05	0.00133	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	3.49e-05	0.00133	CbGpPWpGaD
Meloxicam—PGD—Disease—PTEN—head and neck cancer	3.48e-05	0.00132	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	3.37e-05	0.00128	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—NAT2—head and neck cancer	3.37e-05	0.00128	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTGS2—head and neck cancer	3.34e-05	0.00127	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	3.33e-05	0.00126	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.31e-05	0.00126	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	3.2e-05	0.00122	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	3.2e-05	0.00122	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.15e-05	0.0012	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	3.15e-05	0.0012	CbGpPWpGaD
Meloxicam—PGD—Disease—STAT3—head and neck cancer	3.11e-05	0.00118	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—IL2—head and neck cancer	3.04e-05	0.00116	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	2.98e-05	0.00113	CbGpPWpGaD
Meloxicam—PGD—Disease—MAPK3—head and neck cancer	2.97e-05	0.00113	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—DPYD—head and neck cancer	2.95e-05	0.00112	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTEN—head and neck cancer	2.92e-05	0.00111	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.84e-05	0.00108	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.84e-05	0.00108	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.84e-05	0.00108	CbGpPWpGaD
Meloxicam—PGD—Disease—MAPK1—head and neck cancer	2.83e-05	0.00108	CbGpPWpGaD
Meloxicam—PGD—Disease—EGFR—head and neck cancer	2.83e-05	0.00108	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—UROD—head and neck cancer	2.81e-05	0.00107	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.81e-05	0.00107	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—YAP1—head and neck cancer	2.8e-05	0.00107	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NAT2—head and neck cancer	2.67e-05	0.00102	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VEGFA—head and neck cancer	2.59e-05	0.000983	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.46e-05	0.000936	CbGpPWpGaD
Meloxicam—PGD—Disease—PIK3CA—head and neck cancer	2.46e-05	0.000934	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MAPK3—head and neck cancer	2.45e-05	0.00093	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.38e-05	0.000906	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—DPYD—head and neck cancer	2.34e-05	0.000891	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MAPK1—head and neck cancer	2.33e-05	0.000885	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.31e-05	0.000878	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.29e-05	0.00087	CbGpPWpGaD
Meloxicam—PGD—Disease—HRAS—head and neck cancer	2.27e-05	0.000864	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—YAP1—head and neck cancer	2.22e-05	0.000846	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NAT2—head and neck cancer	2.18e-05	0.000827	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.11e-05	0.000801	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CA—head and neck cancer	2.06e-05	0.000782	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CA—head and neck cancer	2.02e-05	0.000768	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.01e-05	0.000765	CbGpPWpGaD
Meloxicam—PGD—Disease—AKT1—head and neck cancer	2.01e-05	0.000763	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TP53—head and neck cancer	1.95e-05	0.000743	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—DPYD—head and neck cancer	1.91e-05	0.000725	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.88e-05	0.000715	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—HRAS—head and neck cancer	1.87e-05	0.00071	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.86e-05	0.000708	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.84e-05	0.000698	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—YAP1—head and neck cancer	1.81e-05	0.000688	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NAT2—head and neck cancer	1.77e-05	0.000673	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—TYMS—head and neck cancer	1.68e-05	0.00064	CbGpPWpGaD
Meloxicam—PGD—Metabolism—AKT1—head and neck cancer	1.68e-05	0.000639	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTM1—head and neck cancer	1.66e-05	0.000632	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—AKT1—head and neck cancer	1.65e-05	0.000627	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GPX1—head and neck cancer	1.59e-05	0.000606	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP1A1—head and neck cancer	1.58e-05	0.0006	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—DPYD—head and neck cancer	1.55e-05	0.00059	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—YAP1—head and neck cancer	1.47e-05	0.00056	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.46e-05	0.000554	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.36e-05	0.000517	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—TYMS—head and neck cancer	1.34e-05	0.000508	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTM1—head and neck cancer	1.32e-05	0.000502	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.3e-05	0.000493	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GPX1—head and neck cancer	1.26e-05	0.000481	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP1A1—head and neck cancer	1.25e-05	0.000476	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOTCH1—head and neck cancer	1.2e-05	0.000455	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.19e-05	0.000451	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NAT2—head and neck cancer	1.17e-05	0.000444	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.11e-05	0.000421	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—TYMS—head and neck cancer	1.09e-05	0.000413	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.07e-05	0.000409	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GPX1—head and neck cancer	1.03e-05	0.000391	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.03e-05	0.000391	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—DPYD—head and neck cancer	1.02e-05	0.000389	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.02e-05	0.000387	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—YAP1—head and neck cancer	9.72e-06	0.000369	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.65e-06	0.000367	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—head and neck cancer	9.38e-06	0.000357	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—TYMS—head and neck cancer	8.85e-06	0.000336	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTM1—head and neck cancer	8.75e-06	0.000332	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GPX1—head and neck cancer	8.37e-06	0.000318	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.37e-06	0.000318	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP1A1—head and neck cancer	8.29e-06	0.000315	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTEN—head and neck cancer	8.18e-06	0.000311	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PTEN—head and neck cancer	7.75e-06	0.000295	CbGpPWpGaD
Meloxicam—PTGS2—Disease—STAT3—head and neck cancer	6.93e-06	0.000264	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.81e-06	0.000259	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAPK3—head and neck cancer	6.62e-06	0.000252	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PTEN—head and neck cancer	6.49e-06	0.000247	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAPK1—head and neck cancer	6.3e-06	0.00024	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EGFR—head and neck cancer	6.3e-06	0.00024	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—head and neck cancer	6.06e-06	0.00023	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—TYMS—head and neck cancer	5.83e-06	0.000222	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CA—head and neck cancer	5.77e-06	0.000219	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTM1—head and neck cancer	5.77e-06	0.000219	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GPX1—head and neck cancer	5.52e-06	0.00021	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CA—head and neck cancer	5.47e-06	0.000208	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP1A1—head and neck cancer	5.47e-06	0.000208	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTEN—head and neck cancer	5.28e-06	0.000201	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HRAS—head and neck cancer	5.06e-06	0.000192	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—head and neck cancer	4.93e-06	0.000187	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—AKT1—head and neck cancer	4.71e-06	0.000179	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CA—head and neck cancer	4.58e-06	0.000174	CbGpPWpGaD
Meloxicam—PTGS2—Disease—AKT1—head and neck cancer	4.47e-06	0.00017	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTEN—head and neck cancer	4.3e-06	0.000163	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—AKT1—head and neck cancer	3.74e-06	0.000142	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CA—head and neck cancer	3.73e-06	0.000142	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—head and neck cancer	3.25e-06	0.000124	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—AKT1—head and neck cancer	3.04e-06	0.000116	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CA—head and neck cancer	3.03e-06	0.000115	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTEN—head and neck cancer	2.84e-06	0.000108	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—AKT1—head and neck cancer	2.48e-06	9.42e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2e-06	7.61e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—AKT1—head and neck cancer	1.63e-06	6.21e-05	CbGpPWpGaD
